Back to search

Article

Age and baseline creatinine as risk factors for methotrexate nephrotoxicity in children with acute lymphoblastic leukemia in resource-limited countries

2022-07-05

Abstract excerpt

<h4>Introduction: </h4> The search for risk factors for high-dose methotrexate (MTX)–induced nephrotoxicity in children with acute lymphoblastic leukemia (ALL) has been complex in the context of resource-limited countries where serum levels of MTX are not always available. <h4>Objective: </h4> To analyze the demographic, clinical, and biochemical factors associated with MTX-induced nephrotoxicity in children with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
24553fae-2e76-59e8-a506-2991e1b514cf
DOI
10.21203/rs.3.rs-1770424/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Age and baseline creatinine as risk factors for methotrexate nephrotoxicity in children with acute lymphoblastic leukemia in resource-limited countriesDOI 10.21203/rs.3.rs-1770424/v1
Age and baseline creatinine as risk factors for methotrexate nephrotoxicity in children with acute lymphoblastic leukemia in resource-limited countriesSemantic proximity
Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy.Semantic proximity
Evaluation of Methotrexate Toxicity and its Association with ABCB1 Genetic Polymorphism in Children with Acute Lymphoblastic LeukemiaSemantic proximity
Evaluation of cytogenetic and molecular markers with MTX-mediated toxicity in pediatric acute lymphoblastic leukemia patients.Semantic proximity
The Promise of Pharmacogenomics in Reducing Toxicity during Acute Lymphoblastic Leukemia Maintenance TreatmentSemantic proximity
Effects of gene polymorphisms on delayed MTX clearance, toxicity, and metabolomic changes after HD-MTX treatment in children with acute lymphoblastic leukemia.Semantic proximity
Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate.Semantic proximity
Genetic factors involved in delayed methotrexate elimination in children with acute lymphoblastic leukemia.Semantic proximity
Association between NUDT15 rs116855232T/C Genetic Polymorphism and Mercaptopurine Toxicity in Syrian Children with Acute Lymphoblastic LeukemiaSemantic proximity
Association of ABCB1, ABCC5 and xanthine oxidase genetic polymorphisms with methotrexate adverse reactions in Mexican pediatric patients with ALL.Semantic proximity
Pharmacogenetic aspects of efficacy and safety of methotrexate treatment in pediatric acute lymphoblastic leukemia.Semantic proximity
Reduced folate carrier 1 G80A polymorphism is correlated with elevated methotrexate-induced toxicity in pediatric acute lymphoblastic leukemia patients: a systemic meta-analysis.Semantic proximity
Select a neighboring publication to make it the new centre.